vs

Side-by-side financial comparison of ONE LIBERTY PROPERTIES INC (OLP) and Avidity Biosciences, Inc. (RNA). Click either name above to swap in a different company.

ONE LIBERTY PROPERTIES INC is the larger business by last-quarter revenue ($24.7M vs $12.5M, roughly 2.0× Avidity Biosciences, Inc.). ONE LIBERTY PROPERTIES INC runs the higher net margin — 9.7% vs -1398.3%, a 1408.1% gap on every dollar of revenue. On growth, Avidity Biosciences, Inc. posted the faster year-over-year revenue change (434.0% vs 3.7%). Over the past eight quarters, Avidity Biosciences, Inc.'s revenue compounded faster (138.5% CAGR vs 4.4%).

Liberty Media Corporation is an American mass media company founded by John C. Malone in 1991. The company has two divisions, represented by separate tracking stocks, reflecting its ownership stakes in the Formula One Group and Live Nation Entertainment. As of 2025, Liberty Media owned three global motorsport businesses in the form of Formula One, MotoGP and World Superbikes.

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

OLP vs RNA — Head-to-Head

Bigger by revenue
OLP
OLP
2.0× larger
OLP
$24.7M
$12.5M
RNA
Growing faster (revenue YoY)
RNA
RNA
+430.3% gap
RNA
434.0%
3.7%
OLP
Higher net margin
OLP
OLP
1408.1% more per $
OLP
9.7%
-1398.3%
RNA
Faster 2-yr revenue CAGR
RNA
RNA
Annualised
RNA
138.5%
4.4%
OLP

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
OLP
OLP
RNA
RNA
Revenue
$24.7M
$12.5M
Net Profit
$2.4M
$-174.4M
Gross Margin
Operating Margin
28.6%
-1513.5%
Net Margin
9.7%
-1398.3%
Revenue YoY
3.7%
434.0%
Net Profit YoY
-77.1%
-117.0%
EPS (diluted)
$0.10
$-1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OLP
OLP
RNA
RNA
Q4 25
$24.7M
Q3 25
$23.8M
$12.5M
Q2 25
$24.5M
$3.8M
Q1 25
$24.2M
$1.6M
Q4 24
$23.9M
$3.0M
Q3 24
$22.2M
$2.3M
Q2 24
$21.8M
$2.0M
Q1 24
$22.7M
$3.5M
Net Profit
OLP
OLP
RNA
RNA
Q4 25
$2.4M
Q3 25
$10.5M
$-174.4M
Q2 25
$8.4M
$-157.3M
Q1 25
$4.2M
$-115.8M
Q4 24
$10.6M
$-102.3M
Q3 24
$5.2M
$-80.4M
Q2 24
$9.6M
$-70.8M
Q1 24
$5.2M
$-68.9M
Operating Margin
OLP
OLP
RNA
RNA
Q4 25
28.6%
Q3 25
66.7%
-1513.5%
Q2 25
62.6%
-4448.7%
Q1 25
39.8%
-8360.9%
Q4 24
65.0%
-4069.6%
Q3 24
45.0%
-4200.9%
Q2 24
66.0%
-4040.4%
Q1 24
44.1%
-2178.6%
Net Margin
OLP
OLP
RNA
RNA
Q4 25
9.7%
Q3 25
44.1%
-1398.3%
Q2 25
34.3%
-4089.3%
Q1 25
17.2%
-7360.0%
Q4 24
44.1%
-3439.5%
Q3 24
23.3%
-3441.7%
Q2 24
43.8%
-3461.8%
Q1 24
22.7%
-1943.4%
EPS (diluted)
OLP
OLP
RNA
RNA
Q4 25
$0.10
Q3 25
$0.48
$-1.27
Q2 25
$0.39
$-1.21
Q1 25
$0.18
$-0.90
Q4 24
$0.49
$-0.80
Q3 24
$0.23
$-0.65
Q2 24
$0.45
$-0.65
Q1 24
$0.23
$-0.79

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OLP
OLP
RNA
RNA
Cash + ST InvestmentsLiquidity on hand
$14.4M
$350.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$299.6M
$1.9B
Total Assets
$857.6M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OLP
OLP
RNA
RNA
Q4 25
$14.4M
Q3 25
$18.8M
$350.2M
Q2 25
$19.0M
$243.9M
Q1 25
$8.2M
$254.2M
Q4 24
$42.3M
$219.9M
Q3 24
$25.7M
$370.2M
Q2 24
$35.0M
$575.8M
Q1 24
$27.4M
$471.4M
Stockholders' Equity
OLP
OLP
RNA
RNA
Q4 25
$299.6M
Q3 25
$305.6M
$1.9B
Q2 25
$303.4M
$1.2B
Q1 25
$303.2M
$1.3B
Q4 24
$307.4M
$1.4B
Q3 24
$304.2M
$1.5B
Q2 24
$307.3M
$1.2B
Q1 24
$304.8M
$830.9M
Total Assets
OLP
OLP
RNA
RNA
Q4 25
$857.6M
Q3 25
$802.3M
$2.1B
Q2 25
$795.6M
$1.4B
Q1 25
$811.7M
$1.5B
Q4 24
$767.0M
$1.6B
Q3 24
$768.8M
$1.6B
Q2 24
$759.2M
$1.3B
Q1 24
$755.7M
$951.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OLP
OLP
RNA
RNA
Operating Cash FlowLast quarter
$37.5M
$-156.2M
Free Cash FlowOCF − Capex
$-156.9M
FCF MarginFCF / Revenue
-1257.6%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
15.54×
TTM Free Cash FlowTrailing 4 quarters
$-592.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OLP
OLP
RNA
RNA
Q4 25
$37.5M
Q3 25
$10.9M
$-156.2M
Q2 25
$11.2M
$-199.7M
Q1 25
$11.0M
$-124.8M
Q4 24
$39.1M
$-99.9M
Q3 24
$10.0M
$-65.6M
Q2 24
$8.6M
$-65.0M
Q1 24
$8.9M
$-70.4M
Free Cash Flow
OLP
OLP
RNA
RNA
Q4 25
Q3 25
$-156.9M
Q2 25
$-203.0M
Q1 25
$-128.6M
Q4 24
$-103.8M
Q3 24
$-67.3M
Q2 24
$-65.5M
Q1 24
$-71.3M
FCF Margin
OLP
OLP
RNA
RNA
Q4 25
Q3 25
-1257.6%
Q2 25
-5277.1%
Q1 25
-8174.3%
Q4 24
-3491.0%
Q3 24
-2881.8%
Q2 24
-3204.6%
Q1 24
-2012.3%
Capex Intensity
OLP
OLP
RNA
RNA
Q4 25
Q3 25
5.7%
Q2 25
86.9%
Q1 25
238.6%
Q4 24
131.7%
Q3 24
72.9%
Q2 24
26.0%
Q1 24
25.8%
Cash Conversion
OLP
OLP
RNA
RNA
Q4 25
15.54×
Q3 25
1.04×
Q2 25
1.33×
Q1 25
2.65×
Q4 24
3.70×
Q3 24
1.93×
Q2 24
0.90×
Q1 24
1.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons